O McNally

Royal Women's Hospital

Papers

1

Total Citations

15

H-Index

1

About

O McNally is a leading figure in gynecologic oncology, with a primary research focus on conservative surgical management for early-stage cervical cancer. Their most notable contribution is the landmark "23 Concerv" prospective trial, which rigorously evaluated the safety and efficacy of conservative surgery for low-risk, early-stage cervical cancer. This work, cited 15 times, has provided critical evidence supporting fertility-sparing approaches, challenging traditional radical treatments and offering new hope to young patients. McNally's research has thus directly influenced clinical guidelines, balancing oncologic safety with quality of life. Beyond this pivotal study, their broader impact lies in advancing personalized, less invasive surgical strategies in gynecologic cancers. Through this high-impact trial, McNally has established themselves as a key voice in the shift toward de-escalation of therapy, making their work essential reading for clinicians and researchers dedicated to improving outcomes in cervical cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
23 Concerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Royal Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago